Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium

Abstract Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is highly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Society of Hypertension Vol. 2; no. 6; pp. 439 - 447
Main Authors Carneiro, Fernando S., MSc, Carneiro, Zidonia N, Giachini, Fernanda R.C., MSc, Lima, Victor V., BSc, Nogueira, Edson F., MD, Rainey, William E., PhD, Tostes, Rita C., PhD, Webb, R. Clinton, PhD
Format Journal Article
LanguageEnglish
Published United States 01.11.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is highly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II, and IRL-1620, an ETB agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of Nω -nitro-L-arginine methyl ester (L-NAME), or in strips prestimulated with 20 mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation that was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips precontracted with phenylephrine. mRNA expression of ET-1, ETA , ETB , and U-II receptors, but not U-II was observed in cavernosal strips. ET-1, via ETA receptors activation, causes contractile responses in cavernosal strips from rats and mice, whereas ETB receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.
AbstractList Abstract Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is highly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II, and IRL-1620, an ETB agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of Nω -nitro-L-arginine methyl ester (L-NAME), or in strips prestimulated with 20 mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation that was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips precontracted with phenylephrine. mRNA expression of ET-1, ETA , ETB , and U-II receptors, but not U-II was observed in cavernosal strips. ET-1, via ETA receptors activation, causes contractile responses in cavernosal strips from rats and mice, whereas ETB receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.
BACKGROUND: Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is higly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. METHODS AND RESULTS: Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II and IRL-1620, an ET(B) agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of L-NAME, or in strips pre-stimulated with 20mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation which was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips pre-contracted with phenylephrine. mRNA expression of ET-1, ET(A), ET(B) and U-II receptors, but not U-II was observed in cavernosal strips. CONCLUSION: ET-1, via ET(A) receptors activation, causes contractile responses in cavernosal strips from rats and mice whereas ET(B) receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.BACKGROUND: Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is higly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. METHODS AND RESULTS: Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II and IRL-1620, an ET(B) agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of L-NAME, or in strips pre-stimulated with 20mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation which was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips pre-contracted with phenylephrine. mRNA expression of ET-1, ET(A), ET(B) and U-II receptors, but not U-II was observed in cavernosal strips. CONCLUSION: ET-1, via ET(A) receptors activation, causes contractile responses in cavernosal strips from rats and mice whereas ET(B) receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.
BACKGROUND: Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is higly responsive to ET-1, no information exists on the effects of U-II on cavernosal function. The aim of this study was to characterize ET-1 and U-II responses in corpora cavernosa from rats and mice. METHODS AND RESULTS: Male Wistar rats and C57/BL6 mice were used at 13 weeks. Cumulative concentration-response curves to ET-1, U-II and IRL-1620, an ET(B) agonist, were performed. ET-1 increased force generation in cavernosal strips from mice and rats, but no response to U-II was observed in the presence or absence of L-NAME, or in strips pre-stimulated with 20mM KCl. IRL-1620 did not induce cavernosal contraction even in presence of L-NAME, but induced a cavernosal relaxation which was greater in rats than mice. No relaxation responses to U-II were observed in cavernosal strips pre-contracted with phenylephrine. mRNA expression of ET-1, ET(A), ET(B) and U-II receptors, but not U-II was observed in cavernosal strips. CONCLUSION: ET-1, via ET(A) receptors activation, causes contractile responses in cavernosal strips from rats and mice whereas ET(B) receptor activation produces relaxation. Although the cavernosal tissue expresses U-II receptors, U-II does not induce contractile responses in corpora cavernosa from mice or rats.
Author Webb, R. Clinton, PhD
Rainey, William E., PhD
Carneiro, Zidonia N
Lima, Victor V., BSc
Giachini, Fernanda R.C., MSc
Carneiro, Fernando S., MSc
Tostes, Rita C., PhD
Nogueira, Edson F., MD
AuthorAffiliation 2 Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
1 Medical College of Georgia, Department of Physiology, Augusta, GA, USA
AuthorAffiliation_xml – name: 2 Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
– name: 1 Medical College of Georgia, Department of Physiology, Augusta, GA, USA
Author_xml – sequence: 1
  fullname: Carneiro, Fernando S., MSc
– sequence: 2
  fullname: Carneiro, Zidonia N
– sequence: 3
  fullname: Giachini, Fernanda R.C., MSc
– sequence: 4
  fullname: Lima, Victor V., BSc
– sequence: 5
  fullname: Nogueira, Edson F., MD
– sequence: 6
  fullname: Rainey, William E., PhD
– sequence: 7
  fullname: Tostes, Rita C., PhD
– sequence: 8
  fullname: Webb, R. Clinton, PhD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19884966$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk2P1CAYbswa90P_gAfTo5dWoBToxcRsVp1kjSarXt8w9K1DbWEEOsn8e6k7btSDXIDwfITneS-LM-cdFsVzSmpKqHg11qOOu5oRomoia0Loo-KCKqkqyRtxls9d01RUUnpeXMY4EtK2RPInxTntlOKdEBeF_rAE67DUri-DTqXRBwzORz2VAePeu4ixTL5E1_u0w8m6iv4CL8EndDHfN5vyq45em2QPWH7CfbI9lnfHee-jXeanxeNBTxGfnfar4svbm8_X76vbj-82129uK8Nbmaq-N5IR3gwsL9l2aFqF3AzSDA0RUhjFhNaoNJNMC45mMEOrmFGUb_m2Zc1V8fped79sZ-wNuhT0BPtgZx2O4LWFv1-c3cE3fwAmGG1akQVengSC_7FgTDDbaHCatEO_RKCqabnoCCEZ-uJPrweT37lmgLoHmOBjDDiAsUkn61drOwElsFYII6wVwlohEAm5wkxl_1Af1P9HOn0ec8IHiwFMrsoaPX3HI8bRL8Hl8IFCZEDgbp2MdTCIymzOZfMTWfK3ng
CitedBy_id crossref_primary_10_1016_j_niox_2019_10_006
crossref_primary_10_1159_000516600
crossref_primary_10_1016_j_ajur_2024_02_010
crossref_primary_10_1016_j_lfs_2015_09_017
crossref_primary_10_1093_alcalc_agt057
crossref_primary_10_1590_1414_431X20143911
Cites_doi 10.1016/S0022-3565(25)11106-3
10.1016/0014-2999(96)00172-0
10.1124/pr.57.2.5
10.1152/ajpregu.2000.279.1.R25
10.1016/j.vph.2005.03.004
10.1016/S0031-6997(24)01503-5
10.2174/157489007780832579
10.2174/1568006054553390
10.1111/j.1600-0773.1996.tb00245.x
10.1007/s002400050021
10.1016/j.peptides.2005.03.012
10.1016/S0022-5347(01)67390-7
10.1054/plef.1999.0105
10.1161/01.HYP.37.3.974
10.1093/molehr/8.12.1053
10.1111/j.1464-410X.1995.tb07675.x
10.1152/jappl.2001.91.3.1269
10.1002/jand.2002.23.1.76
10.1038/45809
10.1152/ajpregu.00329.2003
10.1016/S0014-5793(01)03015-0
10.1038/sj.ijir.3900773
10.1097/01.ju.0000075362.08363.a4
10.1161/hh1101.092034
10.1517/14728222.12.3.327
10.1016/S0024-3205(02)02346-9
10.1038/sj.bjp.0705954
10.1016/S0022-5347(01)64195-8
10.1111/j.1743-6109.2007.00752.x
10.1038/sj.ijir.3900793
10.1006/bbrc.1999.1796
10.1016/S0022-5347(17)37667-X
10.1093/ndt/gfg299
10.1038/sj.bjp.0703513
10.1038/sj.bjp.0703690
ContentType Journal Article
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1016/j.jash.2008.07.001
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-7436
EndPage 447
ExternalDocumentID PMC2621356
19884966
10_1016_j_jash_2008_07_001
1_s2_0_S1933171108001447
Genre Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: P01 HL074167
– fundername: NHLBI NIH HHS
  grantid: R01 HL071138
GroupedDBID ---
--K
--M
-RU
.~1
0R~
1B1
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AAEDT
AAIKJ
AALRI
AAOAW
AAXLA
AAXUO
ABBQC
ABCQJ
ABJNI
ABMZM
ABWVN
ABXDB
ACGFS
ACRPL
ADEZE
ADMUD
ADNMO
AEKER
AENEX
AFTJW
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
ANZVX
BLXMC
CS3
DU5
EBS
EJD
F5P
FDB
FEDTE
FIRID
FNPLU
GBLVA
HVGLF
HZ~
IHE
J1W
MO0
MOBAO
N9A
NQ-
O-L
O9-
OAUVE
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SEL
SES
T5K
~G-
AAYXX
AIGII
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c457t-ddc72043f2222759ec58e4cf7cf30676c826aae8a272a64ecfcf582c814b4b523
ISSN 1933-1711
1878-7436
IngestDate Thu Aug 21 14:01:09 EDT 2025
Thu Jul 10 18:42:03 EDT 2025
Mon Jul 21 05:59:13 EDT 2025
Tue Jul 01 00:35:34 EDT 2025
Thu Apr 24 23:10:09 EDT 2025
Sun Feb 23 10:19:26 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords DOCA-salt hypertension
ET A receptor
erectile dysfunction
corpus cavernosum
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c457t-ddc72043f2222759ec58e4cf7cf30676c826aae8a272a64ecfcf582c814b4b523
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/j.jash.2008.07.001
PMID 19884966
PQID 1835469000
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2621356
proquest_miscellaneous_1835469000
pubmed_primary_19884966
crossref_citationtrail_10_1016_j_jash_2008_07_001
crossref_primary_10_1016_j_jash_2008_07_001
elsevier_clinicalkeyesjournals_1_s2_0_S1933171108001447
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-11-01
PublicationDateYYYYMMDD 2008-11-01
PublicationDate_xml – month: 11
  year: 2008
  text: 2008-11-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American Society of Hypertension
PublicationTitleAlternate J Am Soc Hypertens
PublicationYear 2008
References Sauzeau (10.1016/j.jash.2008.07.001_bib20) 2001; 88
Bottrill (10.1016/j.jash.2008.07.001_bib21) 2000; 130
Saenz de Tejada (10.1016/j.jash.2008.07.001_bib5) 1991; 261
Dai (10.1016/j.jash.2008.07.001_bib10) 2000; 279
Holmquist (10.1016/j.jash.2008.07.001_bib6) 1992; 261
Carneiro (10.1016/j.jash.2008.07.001_bib24) 2008; 5
Meuleman (10.1016/j.jash.2008.07.001_bib23) 2002; 14
Italiano (10.1016/j.jash.2008.07.001_bib29) 1998; 26
Mills (10.1016/j.jash.2008.07.001_bib13) 2001; 91
Peng (10.1016/j.jash.2008.07.001_bib32) 2001; 37
Gendron (10.1016/j.jash.2008.07.001_bib19) 2005; 26
Holmquist (10.1016/j.jash.2008.07.001_bib28) 1992; 147
Sullivan (10.1016/j.jash.2008.07.001_bib7) 1997; 158
Bell (10.1016/j.jash.2008.07.001_bib9) 1995; 76
Christ (10.1016/j.jash.2008.07.001_bib31) 1995; 153
Liu (10.1016/j.jash.2008.07.001_bib18) 1999; 266
Wingard (10.1016/j.jash.2008.07.001_bib14) 2003; 285
Leite (10.1016/j.jash.2008.07.001_bib3) 2007; 2
Andersson (10.1016/j.jash.2008.07.001_bib2) 2003; 170
Schiffrin (10.1016/j.jash.2008.07.001_bib15) 2005; 43
Hartner (10.1016/j.jash.2008.07.001_bib33) 2003; 18
Gardiner (10.1016/j.jash.2008.07.001_bib26) 2004; 143
Andersson (10.1016/j.jash.2008.07.001_bib1) 2001; 53
Granchi (10.1016/j.jash.2008.07.001_bib4) 2002; 8
Tamura (10.1016/j.jash.2008.07.001_bib36) 2003; 72
Zou (10.1016/j.jash.2008.07.001_bib35) 2001; 508
Parkkisenniemi (10.1016/j.jash.2008.07.001_bib11) 1996; 79
Foord (10.1016/j.jash.2008.07.001_bib34) 2005; 57
Kim (10.1016/j.jash.2008.07.001_bib30) 2002; 23
Ari (10.1016/j.jash.2008.07.001_bib12) 1996; 307
Ames (10.1016/j.jash.2008.07.001_bib17) 1999; 401
Chitaley (10.1016/j.jash.2008.07.001_bib25) 2001; 13
Khan (10.1016/j.jash.2008.07.001_bib8) 1999; 61
Douglas (10.1016/j.jash.2008.07.001_bib22) 2000; 131
Tostes (10.1016/j.jash.2008.07.001_bib16) 2005; 5
Giachini (10.1016/j.jash.2008.07.001_bib27) 2008; 12
References_xml – volume: 261
  start-page: 795
  year: 1992
  ident: 10.1016/j.jash.2008.07.001_bib6
  article-title: Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)11106-3
– volume: 307
  start-page: 69
  year: 1996
  ident: 10.1016/j.jash.2008.07.001_bib12
  article-title: Possible role for endothelins in penile erection
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(96)00172-0
– volume: 57
  start-page: 279
  year: 2005
  ident: 10.1016/j.jash.2008.07.001_bib34
  article-title: International Union of Pharmacology
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.57.2.5
– volume: 279
  start-page: R25
  year: 2000
  ident: 10.1016/j.jash.2008.07.001_bib10
  article-title: Receptor-specific influence of endothelin-1 in the erectile response of the rat
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.2000.279.1.R25
– volume: 43
  start-page: 19
  year: 2005
  ident: 10.1016/j.jash.2008.07.001_bib15
  article-title: Vascular endothelin in hypertension
  publication-title: Vascul Pharmacol
  doi: 10.1016/j.vph.2005.03.004
– volume: 53
  start-page: 417
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib1
  article-title: Pharmacology of penile erection
  publication-title: Pharmacol Rev
  doi: 10.1016/S0031-6997(24)01503-5
– volume: 2
  start-page: 119
  year: 2007
  ident: 10.1016/j.jash.2008.07.001_bib3
  article-title: Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer?
  publication-title: Recent Patents Cardiovasc Drug Discov
  doi: 10.2174/157489007780832579
– volume: 5
  start-page: 287
  year: 2005
  ident: 10.1016/j.jash.2008.07.001_bib16
  article-title: Endothelin receptor antagonists: another potential alternative for cardiovascular diseases
  publication-title: Curr Drug Targets Cardiovasc Haematol Disord
  doi: 10.2174/1568006054553390
– volume: 79
  start-page: 73
  year: 1996
  ident: 10.1016/j.jash.2008.07.001_bib11
  article-title: Functional characterization of endothelin receptors in the bovine retractor penis muscle and penile artery
  publication-title: Pharmacol Toxicol
  doi: 10.1111/j.1600-0773.1996.tb00245.x
– volume: 26
  start-page: 39
  year: 1998
  ident: 10.1016/j.jash.2008.07.001_bib29
  article-title: Functional response of cavernosal tissue to distension
  publication-title: Urol Res
  doi: 10.1007/s002400050021
– volume: 26
  start-page: 1468
  year: 2005
  ident: 10.1016/j.jash.2008.07.001_bib19
  article-title: Urotensin II-induced hypotensive responses in Wistar-Kyoto (WKY) and spontaneously hypertensive (Shr) rats
  publication-title: Peptides
  doi: 10.1016/j.peptides.2005.03.012
– volume: 153
  start-page: 1998
  year: 1995
  ident: 10.1016/j.jash.2008.07.001_bib31
  article-title: Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)67390-7
– volume: 61
  start-page: 307
  year: 1999
  ident: 10.1016/j.jash.2008.07.001_bib8
  article-title: Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction
  publication-title: Prostaglandins Leukot Essent Fatty Acids
  doi: 10.1054/plef.1999.0105
– volume: 37
  start-page: 974
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib32
  article-title: Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene
  publication-title: Hypertension
  doi: 10.1161/01.HYP.37.3.974
– volume: 8
  start-page: 1053
  year: 2002
  ident: 10.1016/j.jash.2008.07.001_bib4
  article-title: Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells
  publication-title: Mol Hum Reprod
  doi: 10.1093/molehr/8.12.1053
– volume: 76
  start-page: 203
  year: 1995
  ident: 10.1016/j.jash.2008.07.001_bib9
  article-title: The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum
  publication-title: Br J Urol
  doi: 10.1111/j.1464-410X.1995.tb07675.x
– volume: 91
  start-page: 1269
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib13
  article-title: Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.2001.91.3.1269
– volume: 261
  start-page: H1078
  year: 1991
  ident: 10.1016/j.jash.2008.07.001_bib5
  article-title: Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum
  publication-title: Am J Physiol
– volume: 23
  start-page: 76
  year: 2002
  ident: 10.1016/j.jash.2008.07.001_bib30
  article-title: Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction
  publication-title: J Androl
  doi: 10.1002/jand.2002.23.1.76
– volume: 401
  start-page: 282
  year: 1999
  ident: 10.1016/j.jash.2008.07.001_bib17
  article-title: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
  publication-title: Nature
  doi: 10.1038/45809
– volume: 285
  start-page: R1145
  year: 2003
  ident: 10.1016/j.jash.2008.07.001_bib14
  article-title: RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00329.2003
– volume: 508
  start-page: 57
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib35
  article-title: Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(01)03015-0
– volume: 13
  start-page: S16
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib25
  article-title: Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats
  publication-title: Int J Impot Res
  doi: 10.1038/sj.ijir.3900773
– volume: 170
  start-page: S6
  year: 2003
  ident: 10.1016/j.jash.2008.07.001_bib2
  article-title: Erectile physiological and pathophysiological pathways involved in erectile dysfunction
  publication-title: J Urol
  doi: 10.1097/01.ju.0000075362.08363.a4
– volume: 88
  start-page: 1102
  year: 2001
  ident: 10.1016/j.jash.2008.07.001_bib20
  article-title: Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase
  publication-title: Circ Res
  doi: 10.1161/hh1101.092034
– volume: 12
  start-page: 327
  year: 2008
  ident: 10.1016/j.jash.2008.07.001_bib27
  article-title: Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.12.3.327
– volume: 72
  start-page: 1049
  year: 2003
  ident: 10.1016/j.jash.2008.07.001_bib36
  article-title: Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(02)02346-9
– volume: 143
  start-page: 422
  year: 2004
  ident: 10.1016/j.jash.2008.07.001_bib26
  article-title: Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0705954
– volume: 158
  start-page: 1966
  year: 1997
  ident: 10.1016/j.jash.2008.07.001_bib7
  article-title: Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)64195-8
– volume: 5
  start-page: 1156
  year: 2008
  ident: 10.1016/j.jash.2008.07.001_bib24
  article-title: Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db Mouse
  publication-title: J Sex Med
  doi: 10.1111/j.1743-6109.2007.00752.x
– volume: 14
  start-page: S22
  year: 2002
  ident: 10.1016/j.jash.2008.07.001_bib23
  article-title: Prevalence of erectile dysfunction: need for treatment?
  publication-title: Int J Impot Res
  doi: 10.1038/sj.ijir.3900793
– volume: 266
  start-page: 174
  year: 1999
  ident: 10.1016/j.jash.2008.07.001_bib18
  article-title: Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1999.1796
– volume: 147
  start-page: 1632
  year: 1992
  ident: 10.1016/j.jash.2008.07.001_bib28
  article-title: Phospholipase C activation by endothelin-1 and noradrenaline in isolated penile erectile tissue from rabbit
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)37667-X
– volume: 18
  start-page: 1999
  year: 2003
  ident: 10.1016/j.jash.2008.07.001_bib33
  article-title: Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfg299
– volume: 130
  start-page: 1865
  year: 2000
  ident: 10.1016/j.jash.2008.07.001_bib21
  article-title: Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0703513
– volume: 131
  start-page: 1262
  year: 2000
  ident: 10.1016/j.jash.2008.07.001_bib22
  article-title: Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0703690
SSID ssj0055074
Score 1.7948825
Snippet Abstract Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is highly responsive to...
BACKGROUND: Endothelin-1 (ET-1) and urotensin-II (U-II) are the most potent constrictors of human vessels. Although the cavernosal tissue is higly responsive...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 439
SubjectTerms Cardiovascular
Title Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1933171108001447
https://www.ncbi.nlm.nih.gov/pubmed/19884966
https://www.proquest.com/docview/1835469000
https://pubmed.ncbi.nlm.nih.gov/PMC2621356
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaqRUJcEG_KS0biFiVaO06aHFEF7CK6QnS3WnGJHMfRpmIT1LQHOPCX-IvMxM6j7S5iuURt4qRJv8l4ZvzNDCFveCxATELfTeOMu4Kp1JUsz-F1B2vZ90Ugm9DF7CQ8OhMfz4Pz0ej3gLW0Waee-nllXsn_oAr7AFfMkr0Bst1FYQd8BnxhCwjD9p8wnmGo3MT_AUhHSeybW9VNrf6G-mrqN-gywzwrMChd1gzeYHGGsobvx8fOQtaVbLSe8xkpLpl25j8ukcxlqzTsm66DdJSy433iigA4tavmyv3i_lSuSl2YbBobtK6cuXfV4a9FVmGS2El39EPRcD2LwcnS-eJNuwGfisvG-l0UuPjgLLytKEZk0_l6xRv7WCrVKl6rmflAAIdaVpj6R3bCFqZk595cYMISS28p6wtLmsVylayf-drV_p0JsaMptgy4ZYLXsB07cb0e3O1bHPwSbJnh_eo4RVgbztIYzMPYLC1DKNy9j-ssoX1PZ5ewO7CATu-RuxZ_-tbI4X0y0uUDcntmyRkPiTTiSAEkCuJIe3GknTjSdUWH4tgMHooj7cWRWnGknTg-Imfv351Oj1zbwcNVIpis3SxT2ATJzzmmXAexVkGkhconKkdXNVTg3EqpI8knXIZCq1zlQcRVxEQq0oD7j8lBWZX6KaGHhzLN_TBNeSQFVzoOtBCah2msGVMiHxPW_puJsuXtscvKt-R6FMfE6c75boq7_HX0pAUpadOWYaLVtdUIdcKSmieHyRzxR_jRG2MgnmPyusU0Ae2NS3Ky1NUGzsC4a4iNe8fkicG4v5M4ikQchvC7W-h3A7Ay_PaRsrhoKsTzkDM_CJ_d6Pmekzv9m_mCHKxXG_0SLO51-qqR8j8cVtmy
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Murine+and+rat+cavernosal+responses+to+endothelin-1+and+urotensin-II+Vasoactive+Peptide+Symposium&rft.jtitle=Journal+of+the+American+Society+of+Hypertension&rft.au=Carneiro%2C+Fernando+S.&rft.au=Carneiro%2C+Zidonia+N.&rft.au=Giachini%2C+Fernanda+R.C.&rft.au=Lima%2C+Victor+V.&rft.date=2008-11-01&rft.issn=1933-1711&rft.volume=2&rft.issue=6&rft.spage=439&rft.epage=447&rft_id=info:doi/10.1016%2Fj.jash.2008.07.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jash_2008_07_001
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F19331711%2FS1933171108X00075%2Fcov150h.gif